Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $963.92 | 44 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $156.47 | 6 | $0 (2020) |
| Fresenius USA Marketing, Inc. | $130.81 | 8 | $0 (2022) |
| Aurinia Pharma U.S., Inc. | $125.36 | 5 | $0 (2022) |
| BARD PERIPHERAL VASCULAR, INC. | $98.99 | 1 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $91.07 | 6 | $0 (2021) |
| Relypsa, Inc. | $78.96 | 5 | $0 (2020) |
| NxStage Medical, Inc. | $75.00 | 1 | $0 (2018) |
| Mallinckrodt Enterprises LLC | $59.71 | 3 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $40.62 | 2 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $32.80 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $17.63 | 1 | MAYNE PHARMA COMMERCIAL LLC ($17.63) |
| 2022 | $81.67 | 4 | Aurinia Pharma U.S., Inc. ($49.25) |
| 2021 | $207.87 | 11 | Aurinia Pharma U.S., Inc. ($76.11) |
| 2020 | $111.38 | 7 | AstraZeneca Pharmaceuticals LP ($48.84) |
| 2019 | $327.61 | 13 | BARD PERIPHERAL VASCULAR, INC. ($98.99) |
| 2018 | $207.02 | 7 | Amgen Inc. ($80.08) |
| 2017 | $10.74 | 1 | Teleflex Medical Incorporated ($10.74) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/04/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $17.63 | General |
| 05/20/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 04/22/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Cardio-renal | ||||||
| 02/18/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Phosphate binder for ESRD | ||||||
| 01/21/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/22/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Cardio-renal | ||||||
| 10/06/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 09/17/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/20/2021 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/04/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 07/15/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/02/2021 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Phosphate binder for ESRD | ||||||
| 05/05/2021 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Hyperkalemia | ||||||
| 04/09/2021 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Phosphate binder for ESRD | ||||||
| 03/17/2021 | Medtronic, Inc. | Ellipsys (Device) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Catheters | ||||||
| 01/04/2021 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Phosphate binder for ESRD | ||||||
| 09/02/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/01/2020 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Nephrology | ||||||
| 06/03/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/17/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/04/2020 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Hyperkalemia | ||||||
| 02/12/2020 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Phosphate binder for ESRD | ||||||
| 01/08/2020 | Alexion Pharmaceuticals, Inc. | Ultomiris (Drug) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: Immunology | ||||||
| 12/04/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: NEPHROLOGY | ||||||
| 11/06/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 42 | 99 | $14,256 | $5,027 |
| 2021 | 5 | 176 | 344 | $56,814 | $21,149 |
| 2020 | 7 | 391 | 875 | $144,373 | $55,576 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 29 | 78 | $10,056 | $3,976 | 39.5% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 13 | 21 | $4,200 | $1,051 | 25.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 80 | 179 | $21,480 | $9,735 | 45.3% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 43 | 70 | $14,000 | $3,746 | 26.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 14 | 39 | $9,360 | $2,716 | 29.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 16 | 33 | $7,029 | $2,585 | 36.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 23 | 23 | $4,945 | $2,367 | 47.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 146 | 434 | $53,864 | $24,502 | 45.5% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2020 | 106 | 244 | $48,800 | $14,040 | 28.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 63 | 66 | $14,190 | $7,039 | 49.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 28 | 53 | $11,471 | $4,616 | 40.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 19 | 43 | $10,320 | $2,452 | 23.8% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2020 | 17 | 18 | $3,960 | $1,951 | 49.3% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2020 | 12 | 17 | $1,768 | $975.19 | 55.2% |
About Stacy Johnson, M.D., PH.D
Stacy Johnson, M.D., PH.D is a Nephrology healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/14/2009. The National Provider Identifier (NPI) number assigned to this provider is 1912131236.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stacy Johnson, M.D., PH.D has received a total of $963.92 in payments from pharmaceutical and medical device companies, with $17.63 received in 2023. These payments were reported across 44 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($963.92).
As a Medicare-enrolled provider, Johnson has provided services to 609 Medicare beneficiaries, totaling 1,318 services with total Medicare billing of $81,752. Data is available for 3 years (2020–2022), covering 14 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Memphis, TN
- Active Since 05/14/2009
- Last Updated 10/08/2018
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1912131236
Products in Payments
- Parsabiv (Biological) $135.52
- LUPKYNIS (Drug) $125.36
- Veltassa (Drug) $98.70
- Velphoro (Drug) $98.22
- LOKELMA (Drug) $91.07
- System One (Device) $75.00
- ACTHAR (Biological) $59.71
- JYNARQUE (Drug) $40.62
- Kerendia (Drug) $32.80
- Parsabiv (Drug) $20.95
- Ellipsys (Device) $13.54
- Ultomiris (Drug) $12.48
- Percutaneous Solutions: PERCUVANCE & MiniLap brands (Device) $10.74
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Memphis
Dr. Omar Davis, M.d, M.D
Nephrology — Payments: $57,405
Dr. Natarsha Grant, Md, MD
Nephrology — Payments: $34,340
Dr. Robert Canada, Md, MD
Nephrology — Payments: $21,903
Dr. Wael Hussein
Nephrology — Payments: $15,498
Minesh Pathak, M.d, M.D
Nephrology — Payments: $13,583
L Quarles, M.d, M.D
Nephrology — Payments: $12,060